×
ADVERTISEMENT

International AIDS Conference

New Studies Show Neural Tube Risk With Dolutegravir Lower Than Thought

WHO updated its global HIV treatment recommendations based on new data showing that even though dolutegravir during ...

JULY 24, 2019

Truvada for PrEP Led to Significant Declines in New HIV Infections

Thanks to PrEP, the United States has seen a decrease in HIV diagnoses.

JULY 24, 2018

Load more